WASHINGTON – U.S. Senators Bill Cassidy, M.D. (R-LA) and Chris Van Hollen (D-MD) introduced life-saving legislation to cure low-income and hard-to-reach Americans with hepatitis C virus (HCV). Cassidy and Van Hollen’s Cure Hepatitis C Act will establish a voluntary drug subscription model to connect HCV patients to treatment and stop the spread of the disease. Today’s treatment for HCV cures more than 95% of cases with almost no side effects.
“We can virtually eliminate hepatitis C in a fiscally responsible way,” said Dr. Cassidy. “Curing hepatitis C makes Americans healthy again while also saving the federal government billions by eliminating the need for chronic care. It’s a win for patients, and it’s a win for the taxpayers.”
“Hepatitis C claims thousands of American lives every year – but we have a proven model that can make this preventable public health crisis a thing of the past. Our bipartisan legislation offers a solution towards ensuring communities most at risk have access to the highly effective treatments that are available – saving lives while also saving billions in taxpayer dollars that are currently spent on costly chronic care,” said Senator Van Hollen.
The Cure Hepatitis C Act of 2025 is based on a successful pilot program in Louisiana, as well as in other countries. The five-year subscription model allows the federal government to procure HCV drugs through a competitive bidding process between the U.S. Secretary of the Department of Health and Human Services (HHS) and manufacturers and distribute them to HCV patients. Participation is optional, and there are no terms requiring manufacturers to engage in the subscription model. The subscription model is not one-size-fits-all and can be tailored to different populations in need of treatment. State Medicaid programs can opt-in to participate, ensuring that individuals can receive treatment. In addition, individuals receiving care in the Indian Health Program and in federal correctional facilities will have access to HCV treatments through the subscription model. State correctional facilities may opt-in if they choose to do so.
When hepatitis C goes untreated, it can lead to a lifetime of chronic health issues and ultimately be fatal. Chronic health issues are a driving cost for Medicaid and Medicare and increase the amount federal taxpayers spend. Senator Cassidy and Senator Van Hollen’s proposal to reduce the number of hepatitis C cases has been estimated to save $6.6 billion in taxpayer dollars.
###